Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Prospective Observation on the Use of Von Willebrand Factor (VWF) Concentrates in a Large Cohort of Type 3 Von Willebrand Disease (VWD): Interim (18-months) Analyses on 149 Cases Enrolled into the 3Winters-Ips Project

Blood (2018) 132 (Supplement 1): 2464.

https://doi.org/10.1182/blood-2018-99-112447

Published: 2018

Journal Articles

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Blood (2018) 132 (Supplement 1): 2465.

https://doi.org/10.1182/blood-2018-99-113996

Published: 2018

Journal Articles

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Luciano Baronciani, PhD, Flora Peyvandi, MD PhD, Anne Goodeve, PhD, Reinhard Schneppenheim, MDPhD, Zahra Badiee, Mohammad-Reza Baghaipour, Javier Battle, Erik Berntorp, MD PhD, Imre Bodó, MD PhD, Ulrich Budde, MD, Andrea Cairo, PhD, Giancarlo Castaman, Laura Crookes, Jeroen C.J. Eikenboom, MD, Peyman Eshghi, MD, Cosimo Ettorre, MD, Jenny Goudemand, MD PhD, Wolf Hassenpflug, Charles Richard Morris Hay, MDFRCP,FRCPath, Hamid Hoorfar, MD, Mehran Karimi, MD, Bijan Keikhaei, Riitta Lassila, MD PR, Frank W.G. Leebeek, MD PhD, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, MD, Maria Gabriella Mazzucconi, MD, Massimo Morfini, MD, Nikolas Nikšić, Johannes Oldenburg, Florian Oyen, Rafael Parra Lòpez, Ian Peake, PhD, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Sayed Omid Reza Zekavat, MD, Eva M.K. Zetterberg, MD PhD, Augusto B Federici, MD

Blood (2018) 132 (Supplement 1): 1184.

https://doi.org/10.1182/blood-2018-99-114702

Published: 2018

Journal Articles

Imbalance between ADAMTS13 and VWF Activities Might Identify Thrombotic of Bleeding Events in Essential Thrombocythemia (ET): Results from a Cohort of 72 Cases.

Augusto B Federici, MD, Orazio Di Bartolo, MD, Stefania Agnoli, MD, Daniela Intini, Antonella Lattuada, Mariacristina Carraro

Blood (2017) 130 (Supplement 1): 5277.

https://doi.org/10.1182/blood.V130.Suppl_1.5277.5277

Published: 2017

Journal Articles

HDL/ApoA-I: role in VWF-dependent thrombosis

Augusto B. Federici

Blood (2016) 127 (5): 526–528.

https://doi.org/10.1182/blood-2015-12-682484

Published: 2016

Journal Articles

The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease

Augusto B. Federici, Paolo Bucciarelli, Giancarlo Castaman, Maria G. Mazzucconi, Massimo Morfini, Angiola Rocino, Mario Schiavoni, Flora Peyvandi, Francesco Rodeghiero, Pier Mannuccio Mannucci

Blood (2014) 123 (26): 4037–4044.

https://doi.org/10.1182/blood-2014-02-557264

Published: 2014

Journal Articles

Platelet Cut-Off For Anticoagulant Therapy In Cancer Patients With Venous Thromboembolism and Thrombocytopenia: An Expert Opinion Based On RAND/UCLA Appropriateness Method (RAM)

Giorgia Saccullo, MD, Marco Marietta, Monica Carpenedo, Valerio De Stefano, MD, Anna Falanga, Augusto B. Federici, MD, Francesco Rodeghiero, Alberto Tosetto, M.D., Sergio Siragusa, MD

Blood (2013) 122 (21): 581.

https://doi.org/10.1182/blood.V122.21.581.581

Published: 2013

Journal Articles

Treatment of acquired von Willebrand syndrome in childhood

Michael U. Callaghan, Trisha E. Wong, Augusto B. Federici

Blood (2013) 122 (12): 2019–2022.

https://doi.org/10.1182/blood-2012-10-435719

Published: 2013

Journal Articles

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

Jeroen Eikenboom, Augusto B. Federici, Richard J. Dirven, Giancarlo Castaman, Francesco Rodeghiero, Ulrich Budde, Reinhard Schneppenheim, Javier Batlle, Maria Teresa Canciani, Jenny Goudemand, Ian Peake, Anne Goodeve, the MCMDM-1VWD Study Group

Blood (2013) 121 (12): 2336–2339.

https://doi.org/10.1182/blood-2012-09-455089

Published: 2013

Includes: Supplemental data

Journal Articles

Frequency and Determinants of Thrombotic and Bleeding Complications in Ph Negative Myeloproliferative Neoplasms (MPN): The Role of Adamts-13 and VWF Activities in an Italian Cohort 0f 88 Well Characterized Patients

Augusto B. Federici, MD, Maria C Carraro, Antonella Lattuada, Chiara Vanelli, Veronica Sciumbata, Valentina Rossi, MD, Daniela Intini, Sarah Birindelli, Sara Munizza, Elisabetta Sacchi, Umberto Russo, Ulrich Budde, MD

Blood (2012) 120 (21): 3369.

https://doi.org/10.1182/blood.V120.21.3369.3369

Published: 2012

Journal Articles

Intracellular Retention, Enhanced Clearance, and Defective FVIII Binding Are Common Features of Von Willebrand Factor D'-D3 Domain Mutations in Patients with Von Willebrand Disease Type 1 From the European Mcmdm-1VWD Study

Reinhard Schneppenheim, MD, PhD, Ulrich Budde, MD, Javier Batlle, MD, Giancarlo Castaman, MD, Jeroen C. J. Eikenboom, MD, PhD, Augusto B. Federici, MD, Jenny Goudemand, MD, PhD, Tobias Obser, Florian Oyen, Francesco Rodeghiero, MD, Sonja Schneppenheim, MD, Ian R. Peake, PhD, Anne C. Goodeve, PhD

Blood (2012) 120 (21): 99.

https://doi.org/10.1182/blood.V120.21.99.99

Published: 2012

Journal Articles

Clinical Use of a Von Willebrand Factor with a Low FVIII Content in Von Willebrand Disease Patients Undergoing Surgical Procedures or Deliveries: Results From 5 Prospective Multicenter Studies

Annie Borel-Derlon, MD, PhD, Augusto B. Federici, MD, Jenny Goudemand, MD, PhD, Catherine Chatelanaz, Celine Henriet, Françoise Bridey

Blood (2011) 118 (21): 383.

https://doi.org/10.1182/blood.V118.21.383.383

Published: 2011

Journal Articles

Lymphoproliferative Disorder and Acquired C1-INH Deficiency. A Case Series of 48 Patients

Fabrizio Foieni, MD, Andrea Zanichelli, MD, Anna Coerezza, MD, Roberto Castelli, MD, Lorena Maggioni, PhD, Chiara Suffritti, PhD, Erika Bonanni, Augusto B. Federici, MD, Marco Cicardi, MD

Blood (2011) 118 (21): 1596.

https://doi.org/10.1182/blood.V118.21.1596.1596

Published: 2011

Journal Articles

An intact PDZ motif is essential for correct P2Y 12 purinoceptor traffic in human platelets

Shaista Nisar, Martina E. Daly, Augusto B. Federici, Andrea Artoni, Andrew D. Mumford, Stephen P. Watson, Stuart J. Mundell

Blood (2011) 118 (20): 5641–5651.

https://doi.org/10.1182/blood-2011-02-336826

Published: 2011

Includes: Supplemental data

Journal Articles

How I treat the acquired von Willebrand syndrome

Andreas Tiede, Jacob H. Rand, Ulrich Budde, Arnold Ganser, Augusto B. Federici

Blood (2011) 117 (25): 6777–6785.

https://doi.org/10.1182/blood-2010-11-297580

Published: 2011

Journal Articles

A Two-Year Prospective Study on Bleeding Tendency In 105 Patients with Type 2 A and M Von Willebrand Disease

Giancarlo Castaman, MD, Augusto B. Federici, MD, Luciano Baronciani, Pier M. Mannucci, MD, Francesco Rodeghiero

Blood (2010) 116 (21): 543.

https://doi.org/10.1182/blood.V116.21.543.543

Published: 2010

Journal Articles

Regular Replacement Therapy as Prophylaxis In Severe Forms of Von Willebrand Disease: Initial Results From the Von Willebrand Disease Prophylaxis Network (VWD PN) Study Group

Erik Berntorp, MD, PhD, Thomas C. Abshire, MD, Augusto B. Federici, MD

Blood (2010) 116 (21): 236.

https://doi.org/10.1182/blood.V116.21.236.236

Published: 2010

Journal Articles

Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients

Augusto B. Federici, MD, Alfonso Iorio, MD, Giancarlo Castaman, MD

Blood (2010) 116 (21): 238.

https://doi.org/10.1182/blood.V116.21.238.238

Published: 2010

Journal Articles

Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B

Paquita Nurden, Giuliana Gobbi, Alan Nurden, Jocelyne Enouf, Ibtissam Youlyouz-Marfak, Cecilia Carubbi, Silvia La Marca, Margherita Punzo, Luciano Baronciani, Luigi De Marco, Marco Vitale, Augusto B. Federici

Blood (2010) 115 (13): 2649–2656.

https://doi.org/10.1182/blood-2009-07-231886

Published: 2010

Journal Articles

Prevalence and Determinants of Bleeding in Severe Von Willebrand Disease Type 3: Results of Retro/Prospective Studies in a Cohort of 105/52 Italian Patients.

Augusto B. Federici, Paolo Bucciarelli, MD, Alfonso Iorio, Giancarlo Castaman, Maria Gabriella Mazzucconi, Massimo Morfini, Angiola Rocino, MD, Pier M. Mannucci, MD

Blood (2009) 114 (22): 3494.

https://doi.org/10.1182/blood.V114.22.3494.3494

Published: 2009

NARROW

Prospective Observation on the Use of Von Willebrand Factor (VWF) Concentrates in a Large Cohort of Type 3 Von Willebrand Disease (VWD): Interim (18-months) Analyses on 149 Cases Enrolled into the 3Winters-Ips Project

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Imbalance between ADAMTS13 and VWF Activities Might Identify Thrombotic of Bleeding Events in Essential Thrombocythemia (ET): Results from a Cohort of 72 Cases.

HDL/ApoA-I: role in VWF-dependent thrombosis

The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease

Platelet Cut-Off For Anticoagulant Therapy In Cancer Patients With Venous Thromboembolism and Thrombocytopenia: An Expert Opinion Based On RAND/UCLA Appropriateness Method (RAM)

Treatment of acquired von Willebrand syndrome in childhood

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

Frequency and Determinants of Thrombotic and Bleeding Complications in Ph Negative Myeloproliferative Neoplasms (MPN): The Role of Adamts-13 and VWF Activities in an Italian Cohort 0f 88 Well Characterized Patients

Intracellular Retention, Enhanced Clearance, and Defective FVIII Binding Are Common Features of Von Willebrand Factor D'-D3 Domain Mutations in Patients with Von Willebrand Disease Type 1 From the European Mcmdm-1VWD Study

Clinical Use of a Von Willebrand Factor with a Low FVIII Content in Von Willebrand Disease Patients Undergoing Surgical Procedures or Deliveries: Results From 5 Prospective Multicenter Studies

Lymphoproliferative Disorder and Acquired C1-INH Deficiency. A Case Series of 48 Patients

An intact PDZ motif is essential for correct P2Y 12 purinoceptor traffic in human platelets

How I treat the acquired von Willebrand syndrome

A Two-Year Prospective Study on Bleeding Tendency In 105 Patients with Type 2 A and M Von Willebrand Disease

Regular Replacement Therapy as Prophylaxis In Severe Forms of Von Willebrand Disease: Initial Results From the Von Willebrand Disease Prophylaxis Network (VWD PN) Study Group

Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients

Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B

Prevalence and Determinants of Bleeding in Severe Von Willebrand Disease Type 3: Results of Retro/Prospective Studies in a Cohort of 105/52 Italian Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only